A national series of interventions designed to improve the quality of care in health centers for three prevalent chronic conditions has improved processes of care for these conditions but did not improve intermediate clinical outcomes, according to results of a study collaboratively supported by the HHS Agency for Healthcare Research and Quality and Health Resources and Services Administration and complemented by a grant from The Commonwealth Fund.

The study, published in the March 1 New England Journal of Medicine, focuses on the principle quality improvement efforts adopted by HRSA for 1,000 health centers nationally, the Health Disparities Collaboratives. The Health Center Program, administered by HRSA, supports high-quality, comprehensive and community-oriented primary care delivery systems serving low-income residents in inner cities and in rural and isolated areas. The collaborative improvement interventions focused on diabetes, asthma, and hypertension, which together affect more than 25 percent of the U.S. adult population. Health centers provide care for more than 14 million Americans, many of whom are uninsured or underinsured or are members of immigrant or minority groups.

"This study indicates that focused quality improvement interventions can enhance how we deliver care and we need to do more to improve clinical outcomes," said Carolyn M. Clancy, M.D., AHRQ director. "These findings will guide our quality improvement efforts in the overall health care system and at health centers, which are a critically important component of a national strategy to deliver quality care to the medically vulnerable."

"The lessons learned from studies conducted at HRSA's Health Disparities Collaboratives have the potential to save lives and improve the health of thousands of Americans," said Elizabeth M. Duke, HRSA administrator. "We know from experience at hundreds of health centers around the nation that the changes promoted by collaboratives result in verifiable health benefits for patients as they struggle with chronic diseases, which this study confirms."

The interventions teach health center personnel quality improvement methods that require measuring quality performance and continuously implementing and refining small-scale changes that collectively result in improvements in the processes of care. Typically, quality improvement efforts target both processes, such as use of certain tests or medications, which in turn will lead to improvements in intermediate outcomes, such as control of high blood pressure. Improvements in outcomes are more difficult to achieve because of factors that may lie beyond the control of the provider, such as age of the patient or whether the patient complies with medication instructions. Experts therefore also gauge progress by measuring improvements in the processes of care as well as intermediate outcomes.

The researchers led by Bruce E. Landon, M.D., M.B.A., of the Department of Health Care Policy at Harvard Medical School, analyzed interventions with 9,658 patients at 44 health centers nationwide, approximately half of which were in urban areas. They used nationally validated quality measures that were collected from medical record reviews conducted over a 1-year period before the intervention and the same period after the intervention, and judged them against external control centers for comparison.

They found a number of process improvements:

* A 21 percent increase in foot examinations for patients with diabetes.

* A 14 percent increase in the use of anti-inflammatory medication for patients with asthma.

* A 16 percent increase in the level of screening for glycated hemoglobin in persons with diabetes mellitus.

* Overall across the three conditions, a 6 percent improvement in processes of care related to screening and disease prevention and a 5 percent improvement in processes related to disease monitoring and treatment.

However, even though processes were improved, the researchers found no improvement in intermediate outcomes, including:

* Control of glycated hemoglobin for people with diabetes.

* Control of blood pressure to normal levels for patients with hypertension.

* No reduction in urgent care, emergency department visits, or hospitalization for people with asthma.

Researchers observed that this focus on short term outcomes to the exclusion of important longer term outcomes may underestimate the true effect of quality improvement collaboratives.

"There is still much to learn about the tools and methods for quality improvement and their potential effectiveness," Landon said. "The substantial room for improvement in the post intervention period suggests the need for continued refinement of these quality improvement methods."



The Health Disparities Collaboratives bring together health centers to learn and disseminate quality improvement techniques developed by the Institute for Healthcare Improvement and adapted to the health center program. The collaboratives, which focus on improving care for chronic conditions, establish aims based on known quality deficiencies; implement and test small-scale interventions; adopt and refine new practices and procedures based on these tests; and then disseminate the interventions. To date, almost 90 percent of health centers have participated in at least one collaborative in addition to many other quality initiatives.

Contact: AHRQ Public Affairs
Harvard Medical School

Tag Cloud

Buy Actonel Without Prescription
Buy Adefovir Without Prescription
Buy Allopurinol Without Prescription
Buy Antabuse Without Prescription
Buy Arava Without Prescription
Buy Armour Without Prescription
Buy Atarax Without Prescription
Buy Azathioprine Without Prescription
Buy Bayer ASA Aspirin Without Prescription
Buy CellCept Without Prescription
Buy Colchicine Without Prescription
Buy Cyklokapron Without Prescription
Buy Cystone Without Prescription
Buy Detrol Without Prescription
Buy Dexamethasone Without Prescription
Buy Diamox Without Prescription
Buy Diltiazem Cream Without Prescription
Buy Ditropan Without Prescription
Buy Epogen Without Prescription
Buy Fosamax Without Prescription
Buy HIV Test Without Prescription
Buy Human Growth Hormone Without Prescription
Buy Kenalog Without Prescription
Buy Meclizine Without Prescription
Buy Mestinon Without Prescription
Buy Motilium Without Prescription
Buy Naltrexone Without Prescription
Buy Nimotop Without Prescription
Buy Persantine Without Prescription
Buy Potassium Citrate Without Prescription
Buy Prednisolone Without Prescription
Buy Probenecid Without Prescription
Buy Prograf Without Prescription
Buy Pyridium Without Prescription
Buy Reglan Without Prescription
Buy Rocaltrol Without Prescription
Buy Rogaine Without Prescription
Buy Synthroid Without Prescription
Buy Triamcinolone Without Prescription
Buy Urispas Without Prescription
Buy Urivoid Without Prescription
Buy Ursodiol Without Prescription
Buy Vasodilan Without Prescription
Buy Vesicare Without Prescription
Buy Zofran Without Prescription
Buy Anti Flu Face Mask Without Prescription
Buy Anti-Bacterial Face Mask Without Prescription
Buy Atripla Without Prescription
Buy Combivir Without Prescription
Buy Didanosine Without Prescription
Buy Epivir Without Prescription
Buy Famvir Without Prescription
Buy Nevirapine Without Prescription
Buy Retrovir Without Prescription
Buy Ribavirin Without Prescription
Buy Stavudine Without Prescription
Buy Sustiva Without Prescription
Buy Truvada Without Prescription
Buy Valtrex Without Prescription
Buy Zovirax Without Prescription